Abbott Laboratories financial data

Symbol
ABT on NYSE
Industry
Pharmaceutical Preparations
Location
100 Abbott Park Road, Abbott Park, Illinois
State of incorporation
Illinois
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 165 % -7.37%
Quick Ratio 48.7 % +11%
Return On Equity 14.7 % -6.95%
Return On Assets 7.74 % -1.65%
Operating Margin 15.8 % -6.02%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.74B shares +0.04%
Entity Public Float 185B USD -0.5%
Common Stock, Value, Issued 24.7B USD +0.97%
Weighted Average Number of Shares Outstanding, Basic 1.74B shares -0.09%
Weighted Average Number of Shares Outstanding, Diluted 1.75B shares -0.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 40.3B USD -2.84%
Research and Development Expense 2.77B USD -2.6%
Costs and Expenses 34B USD -1.66%
Operating Income (Loss) 6.36B USD -8.68%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6.54B USD -6.49%
Income Tax Expense (Benefit) 908M USD -23.6%
Net Income (Loss) Attributable to Parent 5.63B USD -3%
Earnings Per Share, Basic 3.23 USD/shares -2.42%
Earnings Per Share, Diluted 3.21 USD/shares -2.43%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.28B USD -31.4%
Accounts Receivable, after Allowance for Credit Loss, Current 6.61B USD +9.72%
Inventory, Net 6.83B USD +2.31%
Assets, Current 22.4B USD -8.21%
Property, Plant and Equipment, Net 10.1B USD +8.89%
Operating Lease, Right-of-Use Asset 1.12B USD +0.54%
Intangible Assets, Net (Excluding Goodwill) 8.3B USD -17.1%
Goodwill 23.4B USD +1.99%
Assets 72.5B USD -1.8%
Employee-related Liabilities, Current 1.09B USD -0.55%
Liabilities, Current 14B USD -3.5%
Operating Lease, Liability, Noncurrent 949M USD +0.64%
Other Liabilities, Noncurrent 3.47B USD -8.89%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8.17B USD -1.58%
Retained Earnings (Accumulated Deficit) 38B USD +5.98%
Stockholders' Equity Attributable to Parent 38.8B USD +4.86%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 39B USD +4.86%
Liabilities and Equity 72.5B USD -1.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.03B USD -10.3%
Net Cash Provided by (Used in) Financing Activities -1.18B USD +16.6%
Net Cash Provided by (Used in) Investing Activities -425M USD +8.01%
Common Stock, Shares Authorized 2.4B shares 0%
Common Stock, Shares, Issued 1.99B shares +0.15%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -612M USD +15.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.28B USD -31.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 662M USD +17.6%
Deferred Tax Assets, Valuation Allowance 8.69B USD +643%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 11.6B USD +197%
Operating Lease, Liability 1.19B USD +1.79%
Depreciation 333M USD +5.71%
Payments to Acquire Property, Plant, and Equipment 398M USD +4.74%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.5B USD -11.8%
Lessee, Operating Lease, Liability, to be Paid 1.36B USD +1.57%
Property, Plant and Equipment, Gross 22.1B USD +7.04%
Operating Lease, Liability, Current 245M USD +6.52%
Lessee, Operating Lease, Liability, to be Paid, Year Two 246M USD +12.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 278M USD +7.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +34.5%
Deferred Income Tax Expense (Benefit) -461M USD +30%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 168M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 206M USD +13.2%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 1.4B USD -31%
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 1.34B USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 146M USD -3.31%
Operating Lease, Payments 276M USD +0.73%
Amortization of Intangible Assets 1.95B USD -2.26%
Deferred Tax Assets, Net of Valuation Allowance 2.86B USD +5.3%
Share-based Payment Arrangement, Expense 644M USD -5.99%
Interest Expense 625M USD +7.76%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%